Arroz fermentado vermelho (Portuguese Wikipedia)
Analysis of information sources in references of the Wikipedia article "Arroz fermentado vermelho" in Portuguese language version.
refsWebsite
Global rank
Portuguese rank
610th place
360th place
doi.org
dx.doi.org
- Endo A (outubro de 2004). «The origin of the statins. 2004». Atheroscler Suppl. 5 (3): 125–30. PMID 15531285. doi:10.1016/j.atherosclerosissup.2004.08.033
- Edwards JE, Moore RA (dezembro de 2003). «Statins in hypercholesterolaemia: a dose-specific meta-analysis of lipid changes in randomised, double blind trials». BMC Fam Pract. 4. 18 páginas. PMC 317299
. PMID 14969594. doi:10.1186/1471-2296-4-18 - Becker DJ, Gordon RY, Morris PB, et al. (julho de 2008). «Simvastatin vs therapeutic lifestyle changes and supplements: randomized primary prevention trial». Mayo Clin. Proc. 83 (7): 758–64. PMID 18613992. doi:10.4065/83.7.758
- Li YG, Zhang F, Wang ZT, Hu ZB (setembro de 2004). «Identification and chemical profiling of monacolins in red yeast rice using high-performance liquid chromatography with photodiode array detector and mass spectrometry». J Pharm Biomed Anal. 35 (5): 1101–12. PMID 15336357. doi:10.1016/j.jpba.2004.04.004
- Heber D, Lembertas A, Lu QY, Bowerman S, Go VL (abril de 2001). «An analysis of nine proprietary Chinese red yeast rice dietary supplements: implications of variability in chemical profile and contents». J Altern Complement Med. 7 (2): 133–9. PMID 11327519. doi:10.1089/107555301750164181
- Liu J, Zhang J, Shi Y, Grimsgaard S, Alraek T, Fønnebø V (2006). «Chinese red yeast rice (Monascus purpureus) for primary hyperlipidemia: a meta-analysis of randomized controlled trials». Chin Med. 1. 4 páginas. PMC 1761143. PMID 17302963. doi:10.1186/1749-8546-1-4
- Zhao SP, Lu ZL, Du BM, et al. (fevereiro de 2007). «Xuezhikang, an extract of cholestin, reduces cardiovascular events in type 2 diabetes patients with coronary heart disease: subgroup analysis of patients with type 2 diabetes from China coronary secondary prevention study (CCSPS)». J. Cardiovasc. Pharmacol. 49 (2): 81–4. PMID 17312447. doi:10.1097/FJC.0b013e31802d3a58
- Ye P, Lu ZL, Du BM, et al. (julho de 2007). «Effect of xuezhikang on cardiovascular events and mortality in elderly patients with a history of myocardial infarction: a subgroup analysis of elderly subjects from the China Coronary Secondary Prevention Study». J Am Geriatr Soc. 55 (7): 1015–22. PMID 17608873. doi:10.1111/j.1532-5415.2007.01230.x
- Lu Z, Kou W, Du B, et al. (junho de 2008). «Effect of xuezhikang, an extract from red yeast chinese rice, on coronary events in a chinese population with previous myocardial infarction». Am. J. Cardiol. 101 (12): 1689–93. PMID 18549841. doi:10.1016/j.amjcard.2008.02.056
- Ye P, Wu CE, Sheng L, Li H (julho de 2009). «Potential protective effect of long-term therapy with Xuezhikang on left ventricular diastolic function in patients with essential hypertension». J Altern Complement Med. 15 (7): 719–25. PMID 19552598. doi:10.1089/acm.2008.0599
- Li JJ, Lu ZL, Kou WR, et al. (agosto de 2009). «Beneficial impact of Xuezhikang on cardiovascular events and mortality in elderly hypertensive patients with previous myocardial infarction from the China Coronary Secondary Prevention Study (CCSPS)». J Clin Pharmacol. 49 (8): 947–56. PMID 19602720. doi:10.1177/0091270009337509
- Gordon, R. Y.; Cooperman, T.; Obermeyer, W.; Becker, D. J. (2010). «Marked Variability of Monacolin Levels in Commercial Red Yeast Rice Products: Buyer Beware!». Archives of Internal Medicine. 170 (19): 1722–1727. PMID 20975018. doi:10.1001/archinternmed.2010.382
- Prasad GV, Wong T, Meliton G, Bhaloo S (outubro de 2002). «Rhabdomyolysis due to red yeast rice (Monascus purpureus) in a renal transplant recipient». Transplantation. 74 (8): 1200–1. PMID 12438974. doi:10.1097/01.TP.0000031950.34040.79
- Smith DJ, Olive KE (dezembro de 2003). «Chinese red rice-induced myopathy». South. Med. J. 96 (12): 1265–7. PMID 14696880. doi:10.1097/01.SMJ.0000100117.79718.DC
- Vercelli L, Mongini T, Olivero N, Rodolico C, Musumeci O, Palmucci L (abril de 2006). «Chinese red rice depletes muscle coenzyme Q10 and maintains muscle damage after discontinuation of statin treatment». J Am Geriatr Soc. 54 (4): 718–20. PMID 16686894. doi:10.1111/j.1532-5415.2006.00668_7.x
- Mueller PS (setembro de 2006). «Symptomatic myopathy due to red yeast rice». Ann. Intern. Med. 145 (6): 474–5. PMID 16983142. doi:10.7326/0003-4819-145-6-200609190-00021
- Lapi F, Gallo E, Bernasconi S, et al. (outubro de 2008). «Myopathies associated with red yeast rice and liquorice: spontaneous reports from the Italian Surveillance System of Natural Health Products». Br J Clin Pharmacol. 66 (4): 572–4. PMC 2561108. PMID 18637891. doi:10.1111/j.1365-2125.2008.03224.x
- Roselle H, Ekatan A, Tzeng J, Sapienza M, Kocher J (outubro de 2008). «Symptomatic hepatitis associated with the use of herbal red yeast rice». Ann. Intern. Med. 149 (7): 516–7. PMID 18838736. doi:10.7326/0003-4819-149-7-200810070-00021
- Grieco A, Miele L, Pompili M, et al. (junho de 2009). «Acute hepatitis caused by a natural lipid-lowering product: when "alternative" medicine is no "alternative" at all». J. Hepatol. 50 (6): 1273–7. PMID 19398239. doi:10.1016/j.jhep.2009.02.021
- Becker DJ, Gordon RY, Halbert SC, French B, Morris PB, Rader DJ (junho de 2009). «Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial». Ann. Intern. Med. 150 (12): 830–9, W147–9. PMID 19528562. doi:10.7326/0003-4819-150-12-200906160-00006
- Gabriela Mazzanti, Paola Angela Moro, Emanuel Raschi, Roberto Da Cas, Francesca Menniti-Ippolito. «Adverse reactions to dietary supplements containing red yeast rice: assessment of cases from the Italian surveillance system». Br J Clin Pharmacol. 1365-2125 (em inglês). doi:10.1111/bcp.13171. Consultado em 26 de janeiro de 2017
elsevier.com
linkinghub.elsevier.com
- Lu Z, Kou W, Du B, et al. (junho de 2008). «Effect of xuezhikang, an extract from red yeast chinese rice, on coronary events in a chinese population with previous myocardial infarction». Am. J. Cardiol. 101 (12): 1689–93. PMID 18549841. doi:10.1016/j.amjcard.2008.02.056
fda.gov
nih.gov
ncbi.nlm.nih.gov
- Endo A (outubro de 2004). «The origin of the statins. 2004». Atheroscler Suppl. 5 (3): 125–30. PMID 15531285. doi:10.1016/j.atherosclerosissup.2004.08.033
- Edwards JE, Moore RA (dezembro de 2003). «Statins in hypercholesterolaemia: a dose-specific meta-analysis of lipid changes in randomised, double blind trials». BMC Fam Pract. 4. 18 páginas. PMC 317299. PMID 14969594. doi:10.1186/1471-2296-4-18
- Becker DJ, Gordon RY, Morris PB, et al. (julho de 2008). «Simvastatin vs therapeutic lifestyle changes and supplements: randomized primary prevention trial». Mayo Clin. Proc. 83 (7): 758–64. PMID 18613992. doi:10.4065/83.7.758
- Li YG, Zhang F, Wang ZT, Hu ZB (setembro de 2004). «Identification and chemical profiling of monacolins in red yeast rice using high-performance liquid chromatography with photodiode array detector and mass spectrometry». J Pharm Biomed Anal. 35 (5): 1101–12. PMID 15336357. doi:10.1016/j.jpba.2004.04.004
- Heber D, Lembertas A, Lu QY, Bowerman S, Go VL (abril de 2001). «An analysis of nine proprietary Chinese red yeast rice dietary supplements: implications of variability in chemical profile and contents». J Altern Complement Med. 7 (2): 133–9. PMID 11327519. doi:10.1089/107555301750164181
- Liu J, Zhang J, Shi Y, Grimsgaard S, Alraek T, Fønnebø V (2006). «Chinese red yeast rice (Monascus purpureus) for primary hyperlipidemia: a meta-analysis of randomized controlled trials». Chin Med. 1. 4 páginas. PMC 1761143. PMID 17302963. doi:10.1186/1749-8546-1-4
- Heber D, Yip I, Ashley JM, Elashoff DA, Elashoff RM, Go VL (fevereiro de 1999). «Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement». Am. J. Clin. Nutr. 69 (2): 231–6. PMID 9989685
- Lu ZL; Collaborative Group for China Coronary Secondary Prevention Using Xuezhikang (fevereiro de 2005). «[China coronary secondary prevention study (CCSPS)]». Zhonghua Xin Xue Guan Bing Za Zhi (em chinês). 33 (2): 109–15. PMID 15924803
- Zhao SP, Lu ZL, Du BM, et al. (fevereiro de 2007). «Xuezhikang, an extract of cholestin, reduces cardiovascular events in type 2 diabetes patients with coronary heart disease: subgroup analysis of patients with type 2 diabetes from China coronary secondary prevention study (CCSPS)». J. Cardiovasc. Pharmacol. 49 (2): 81–4. PMID 17312447. doi:10.1097/FJC.0b013e31802d3a58
- Ye P, Lu ZL, Du BM, et al. (julho de 2007). «Effect of xuezhikang on cardiovascular events and mortality in elderly patients with a history of myocardial infarction: a subgroup analysis of elderly subjects from the China Coronary Secondary Prevention Study». J Am Geriatr Soc. 55 (7): 1015–22. PMID 17608873. doi:10.1111/j.1532-5415.2007.01230.x
- Lu Z, Kou W, Du B, et al. (junho de 2008). «Effect of xuezhikang, an extract from red yeast chinese rice, on coronary events in a chinese population with previous myocardial infarction». Am. J. Cardiol. 101 (12): 1689–93. PMID 18549841. doi:10.1016/j.amjcard.2008.02.056
- Ye P, Wu CE, Sheng L, Li H (julho de 2009). «Potential protective effect of long-term therapy with Xuezhikang on left ventricular diastolic function in patients with essential hypertension». J Altern Complement Med. 15 (7): 719–25. PMID 19552598. doi:10.1089/acm.2008.0599
- Li JJ, Lu ZL, Kou WR, et al. (agosto de 2009). «Beneficial impact of Xuezhikang on cardiovascular events and mortality in elderly hypertensive patients with previous myocardial infarction from the China Coronary Secondary Prevention Study (CCSPS)». J Clin Pharmacol. 49 (8): 947–56. PMID 19602720. doi:10.1177/0091270009337509
- Ong HT, Cheah JS (agosto de 2008). «Statin alternatives or just placebo: an objective review of omega-3, red yeast rice and garlic in cardiovascular therapeutics». Chin. Med. J. 121 (16): 1588–94. PMID 18982874
- Gordon, R. Y.; Cooperman, T.; Obermeyer, W.; Becker, D. J. (2010). «Marked Variability of Monacolin Levels in Commercial Red Yeast Rice Products: Buyer Beware!». Archives of Internal Medicine. 170 (19): 1722–1727. PMID 20975018. doi:10.1001/archinternmed.2010.382
- Prasad GV, Wong T, Meliton G, Bhaloo S (outubro de 2002). «Rhabdomyolysis due to red yeast rice (Monascus purpureus) in a renal transplant recipient». Transplantation. 74 (8): 1200–1. PMID 12438974. doi:10.1097/01.TP.0000031950.34040.79
- Smith DJ, Olive KE (dezembro de 2003). «Chinese red rice-induced myopathy». South. Med. J. 96 (12): 1265–7. PMID 14696880. doi:10.1097/01.SMJ.0000100117.79718.DC
- Vercelli L, Mongini T, Olivero N, Rodolico C, Musumeci O, Palmucci L (abril de 2006). «Chinese red rice depletes muscle coenzyme Q10 and maintains muscle damage after discontinuation of statin treatment». J Am Geriatr Soc. 54 (4): 718–20. PMID 16686894. doi:10.1111/j.1532-5415.2006.00668_7.x
- Mueller PS (setembro de 2006). «Symptomatic myopathy due to red yeast rice». Ann. Intern. Med. 145 (6): 474–5. PMID 16983142. doi:10.7326/0003-4819-145-6-200609190-00021
- Lapi F, Gallo E, Bernasconi S, et al. (outubro de 2008). «Myopathies associated with red yeast rice and liquorice: spontaneous reports from the Italian Surveillance System of Natural Health Products». Br J Clin Pharmacol. 66 (4): 572–4. PMC 2561108. PMID 18637891. doi:10.1111/j.1365-2125.2008.03224.x
- Roselle H, Ekatan A, Tzeng J, Sapienza M, Kocher J (outubro de 2008). «Symptomatic hepatitis associated with the use of herbal red yeast rice». Ann. Intern. Med. 149 (7): 516–7. PMID 18838736. doi:10.7326/0003-4819-149-7-200810070-00021
- Grieco A, Miele L, Pompili M, et al. (junho de 2009). «Acute hepatitis caused by a natural lipid-lowering product: when "alternative" medicine is no "alternative" at all». J. Hepatol. 50 (6): 1273–7. PMID 19398239. doi:10.1016/j.jhep.2009.02.021
- Becker DJ, Gordon RY, Halbert SC, French B, Morris PB, Rader DJ (junho de 2009). «Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial». Ann. Intern. Med. 150 (12): 830–9, W147–9. PMID 19528562. doi:10.7326/0003-4819-150-12-200906160-00006
nlm.nih.gov
- «Medline Plus: Red Yeast monograph». Medline Plus
wiley.com
onlinelibrary.wiley.com
- Gabriela Mazzanti, Paola Angela Moro, Emanuel Raschi, Roberto Da Cas, Francesca Menniti-Ippolito. «Adverse reactions to dietary supplements containing red yeast rice: assessment of cases from the Italian surveillance system». Br J Clin Pharmacol. 1365-2125 (em inglês). doi:10.1111/bcp.13171. Consultado em 26 de janeiro de 2017